CRVS Operating Cash Flow (Statement)
Corvus Pharmaceuticals Inc · Operating Cash Flow (Statement)
CRVS Operating Cash Flow (Statement)
Latest reported-$44.53Mperiod ending
CRVS TTM Cash from Operations (-$11.33M → -$44.53M)
TTM operating cash flow (statement)
High-resolution chart · PNG
CRVS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -44,529,000 | |
| -34,908,000 | |
| -32,797,000 | |
| -32,071,000 | |
| -28,826,000 | |
| -28,530,000 | |
| -25,424,000 | |
| -22,126,000 | |
| -21,239,000 | |
| -20,981,000 | |
| -23,935,000 | |
| -26,315,000 | |
| -27,810,000 | |
| -28,710,000 | |
| -27,023,000 | |
| -26,332,000 | |
| -27,828,000 | |
| -34,352,000 | |
| -36,715,000 | |
| -38,066,000 | |
| -37,373,000 | |
| -34,212,000 | |
| -34,778,000 | |
| -35,081,000 | |
| -37,956,000 | |
| -37,684,000 | |
| -37,321,000 | |
| -37,068,000 | |
| -37,258,000 | |
| -38,933,000 | |
| -40,988,000 | |
| -43,710,000 | |
| -43,687,000 | |
| -44,509,000 | |
| -46,212,000 | |
| -44,640,000 | |
| -40,551,000 | |
| -34,969,000 | |
| -27,857,000 | |
| -22,388,000 | |
| -19,055,000 | |
| -14,640,000 | |
| -11,328,000 | |
| -7,494,727 |